MUC16 and benign neoplasm: Biskup et al. reported that GLYCOV (a change in serum polysaccharide group in advanced epithelial tumors) can distinguish advanced epithelial ovarian cancer from benign tumors and early epithelial ovarian cancer in more sensitive and specific compared with CA125 [37].